Clinical trial Recruiting at 1 site Observational Ages 18 and up

Cohort of patients with prosthetic joint infections

Official title: Prospective Cohort of Patients With Prosthetic Joint Infection

Run by Groupe Hospitalier Diaconesses Croix Saint-Simon · NCT02801253 · Data updated 2026-11-12

This study is tracking adults with prosthetic joint infections to see how different treatments affect their recovery and long-term health over two years.

More Prosthetic Joint Infection trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment800 (estimated)
SponsorGroupe Hospitalier Diaconesses Croix Saint-Simon
Academic / other
Locations1 site (Paris, Île-de-France Region)
StatusRecruiting
StartedSeptember 11, 2015
Main results expectedSeptember 2025
Study endsSeptember 2029
Registry record updatedMarch 29, 2022
Trial IDNCT02801253 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old with hip, knee, or shoulder joint prostheses diagnosed with prosthetic joint infections.

Probably not a fit

Patients without a confirmed diagnosis of prosthetic joint infection or those under 18 years old may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study aims to manage and monitor patients with prosthetic joint infections (PJI) at a French referral center. It includes patients over 18 years old who have undergone various treatment strategies for PJI, such as debridement-synovectomy or exchange arthroplasty, and those receiving prolonged suppressive antibiotic therapy. The study will follow participants for at least two years to assess outcomes like reinfection rates, joint revisions, and mortality related to PJI. The study spans a total duration of 10 years, with a recruitment period of 4 years and a maximum data collection period of 6 years.

Why it matters

Potential benefit: If successful, this study could improve the management and treatment strategies for patients suffering from prosthetic joint infections.

How similar studies have gone: While there is a lack of large prospective studies in this area, the approach of long-term follow-up in managing PJI is promising and could provide valuable insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient aged over 18 years old with hip, knee and or shoulder joint prosthesis who consented to participate in the study with:
* According to musculoskeletal infection society definition: PJI is present when one of the major criteria exists or four out of six minor criteria.

Major Criteria:

* Two positive periprosthetic cultures with phenotypically identical organisms, OR
* A sinus tract communicating with the joint, OR

Minor Criteria:

* Elevated serum C-reactive protein (CRP) AND erythrocyte sedimentation rate (ESR)
* Elevated synovial fluid white blood cell (WBC)
* Elevated synovial fluid polymorphonuclear neutrophil percentage (PMN%)
* The presence of pus in the joint without known cause
* Positive histological analysis of periprosthetic tissue
* A single positive culture

Or a PJI which meets the following three criteria:

* Medical story suggesting prosthetic joint infection.
* The presence of pain either with or without swelling for more than 3 months unrelated to a mechanical cause.
* Germ identification in a single sample of fluid aspiration or tissue culture.

  * Or microbial growth in prosthesis sonication fluid culture greater than 50CFU/ml.

Exclusion Criteria:

* Patient who does not meet eligibility criteria.
* Patient lawfully deprived of his liberty.
* Patient not insured under social security scheme.

Where it's running

  • Groupe Hospitalier Diaconesses Croix Saint Simon
    Paris, Île-de-France Region, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.